Trials / Completed
CompletedNCT03623997
Measuring Erythrocyte Iron Incorporation From Different Dosing Regimens in Anemic Women
Defining Systemic Control of Iron Absorption to Optimize Oral Iron Supplementation Regiemns for Women With Iron Deficiency Anemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Swiss Federal Institute of Technology · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Iron-deficient anaemic subjects are likely to benefit most from oral iron supplements, but supplementation schedules vary widely in clinical practice, absorption is low and compliance is poor due to mild gastrointestinal side effects. The investigators will compare iron absorption from labeled oral iron doses of 100mg and 200mg administered either on two consecutive days or on alternate days in young anemic women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Iron stable isotope labeled iron(II) sulfate | Administration of oral stable isotope labels using different dosings and different regimens in women with iron deficiency anemia |
Timeline
- Start date
- 2017-10-10
- Primary completion
- 2018-01-08
- Completion
- 2018-06-30
- First posted
- 2018-08-09
- Last updated
- 2018-08-22
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03623997. Inclusion in this directory is not an endorsement.